RecruitingNCT05404750

Harm Reduction in HIV Primary Care for PLWH Who Use Drugs

Impact of Harm Reduction Care in HIV Clinical Settings on Stigma and Health Outcomes


Sponsor

University of Pittsburgh

Enrollment

768 participants

Start Date

Apr 20, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

People living with HIV (PLWH) who use drugs experience significant health disparities including lower rates of retention in HIV care and higher rates of unsuppressed viral load, resulting in secondary infections and increased mortality. The proposed study will used mixed methods to explore (a) the relationship between healthcare providers' attitudes towards working with PLWH who use drugs and providers' acceptance and practice of structural and relational harm reduction; (b) the degree to which relational harm reduction moderates the effect of intersectional stigma experienced in healthcare settings on patients' perceptions of their relationship with providers; (c) the degree to which structural HR moderates the relationship between the patient-provider relationship and clinical outcomes, and (d) whether patient-perceived HR approaches to care are directly associated with HIV clinical outcomes. The study will also use these findings to inform the development and pre-testing of an intervention to operationalize harm reduction in HIV clinical settings, using stakeholder-engaged and human-centered design approaches, presenting a novel path to reducing HIV health inequities for PLWH who use drugs.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is developing and testing a harm reduction training program for healthcare providers who care for people living with HIV who also use drugs — with the goal of improving how providers integrate substance use support into HIV care. **You may be eligible if...** - You are a healthcare provider (doctor, nurse, pharmacist, social worker, or similar) working at one of the designated HIV care sites - You have worked at the clinic for at least one year - You provide direct care or support services to people living with HIV **You may NOT be eligible if...** - You do not work at one of the participating sites - You have worked at the clinic for less than one year - You are a patient (this study enrolls providers and staff, not patients) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALHarm Reduction

Harm reduction aims to reduce negative effects of risky health behaviors without necessarily terminating the behaviors completely.Though often thought of as structural approaches (e.g., policy or syringe services), Harm reduction is also a relational approach to care focusing on non-punitive patient-provider interactions to promote autonomy. The degree to which harm reduction care is offered in study settings and is associated with clinical outcomes is the focus of this study.


Locations(3)

University of Alabama at Birmingham

Birmingham, Alabama, United States

Allegheny Health Network Research Institute

Pittsburgh, Pennsylvania, United States

University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05404750


Related Trials